3
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Alzheimer's disease—new approaches to old problems

&
Pages 419-435 | Published online: 11 Jul 2009

References

  • Al-Chalabi A., Enayat Z.E., Barker M.C., Sham P.C., Ball D.M., Shaw C.E., Lloyd C.M., Powell J.F., Leigh P.N. Association of apolipoprotein E ε4 allele with bulbar-onset motor neuron disease. Lancet 1996; 347: 159–160
  • Alzheimer A. Uber eine eigenartige Erkrankung der Himrinde. Allgemeine Zeitung der Psychiatric Psychologie und Gerichtliche Medicine 1907; 64: 146–148
  • Amouyel P., Vidal O., Launay J.M., Laplanche J.L. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 1994; 344: 1315–1318
  • Arendt T., Holzer M., Fruth R., Bruckner M.K. PHF-like phosphorylation of tau, deposition of ν/A4-amyloid and cognitive dysfunction in rat after chronic inhibition of phosphatases 1 and 2A. Neuroscience Letters 1995; 691–698
  • Arioka M., Tsukamoto M., Ishiguro K., Kato R., Sato K., Imahori K., Ichida T. τ protein kinase II is involved in the regulation of the normal phosphorylation state of τ protein. Journal of Neurochemistry 1993; 60: 461–468
  • Armstrong R.A. β-amyloid (Aβ) deposition in elderly non-demented patients and patients with Alzheimer's disease. Neuroscience Letters 1994; 178: 59–62
  • Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., Hyman B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992; 42: 631–639
  • Axelman K., Basun H., Winblad B., Lannfelt L. A large Swedish-family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation. Archives of Neurology 1994; 51: 1193–1197
  • Bancher C., Brunner C., Lassmann H., Budka H., Jelltnger K., Wiche G., Settelberger F., Grundke-Iqbal I., Iqbal K., Wisniewski H.M. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Research 1991; 477: 90–99
  • Benjamin R., Leake A., Edwards J.A., McKeith I.G., Ince P.G., Perry R.H., Morris C.M. Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 1994; 343: 1565
  • Benzing W.C., Mufson E.J., Armstrong D.M. Alzheimer's disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative disease unless amyloid β-protein deposition is present. Brain Research 1993; 606: 10–18
  • Biernat J., Gustke N., Drewes G., Mandelkow E.-M., Mandelkow E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding. Neuron 1993; 11: 153–163
  • Binder L.I., Frankfurter A., Rebhun L.I. The distribution of tau in mammalian central nervous system. Journal of Cell Biology 1985; 101: 1371–1378
  • Blessed G., Tomlinson B.E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. British Journal of Psychiatry 1968; 114: 797–811
  • Blocq P., Marinesco G. Sur les lesions et la pathogenie de l'epilepsie dite essentielle. Semaine Medicate 1892; 12: 445–446
  • Bondareff W., Wischik C.M., Novak M., Amos W.B., Klug A., Roth M. Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study. American Journal of Pathology 1990; 137: 711–723
  • Bondareff W., Wischik C.M., Novak M., Roth M. Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease. American Journal of Pathology 1991; 139: 641–647
  • Bondareff W., Mountjoy C.Q., Wischik C.M., Hauser D.L., LaBree L.D., Roth M. Evidence of subtypes of Alzheimer's disease and implications for etiology. Archives of General Psychiatry 1993; 50: 350–356
  • Bondareff W., Harrington C., Wischik C.M., Hauser D.L., Roth M. Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 1994; 53: 158–164
  • Bondareff W., Harrington C.R., Wischik C.M., Hauser D.L., Roth M. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 1995; 54: 657–663
  • Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiology of Aging 1995; 16: 271–278
  • Bramblett G.T., Trojanowski J.Q., Lee V. M.-Y. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent τ and accumulation of abnormal τ-isoforms (A68 proteins). Laboratory Investigation 1992; 66: 212–222
  • Brayne C., Gill C., Huppert F.A., Barkley C., Gehlhaar E., Girling D.M., O'Connor D.W., Paykel E.S. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life. British Journal of Psychiatry 1995; 167: 255–262
  • Brousseau T., Legratn S., Berr C., Gourlet V., Vial O., Amouyel P. Confirmation of the ε4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 1994; 44: 342–344
  • Cai X.-D., Golde T.E., Younkin S.G. Release of excess amyloid τ protein from a mutant amyloid τ protein precursor. Science 1993; 259: 514–516
  • Cairns N.J., Chadwick A., Lantos P.L., Levy R., Rossor M.N. βA4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the βA4 amyloid precursor protein gene and sporadic Alzheimer's disease. Neuroscience Letters 1993; 149: 137–140
  • Castano E.M., Prelu F., Wisniewski T., Go-Labek A., Kumar R.A., Soto C., Frangione B. Fibrilogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochemistry Journal 1995; 306: 599–604
  • Chartier-Harun M.-C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J., Mullan M. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991; 353: 844–846
  • Citron M., Oltersdorf T., Haass C., Mc-Conlogue L., Hung A.Y., Deubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D.J. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease causes increased β-protein production. Nature 1992; 360: 672–674
  • Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type ε4 allele and risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–923
  • Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell P. C., Jr, Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.E., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics 1994; 7: 181–184
  • Crowther R.A., Olesen O.F., Jakes R., Goedert M. The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease. FEBS Letters 1992; 309: 199–202
  • Delaere P., Duyckaerts C., Masters C., Beyreuther K., Piette F., Hauw J.-J. Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed non-demented person. Neuroscience Letters 1990; 116: 87–93
  • Diedrich J.F., Minnigan H., Carp R.I., Whitaker J.N., Race R., Frey W., III, Haase A.T. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. Journal of Virology 1991; 65: 4759–4768
  • Forsell C., Lannfelt L. Amyloid precursor protein mutation at codon 713 (Ala- Val) does not cause schizophrenia: Non-pathogenic variant found at codon 705 (silent). Neuroscience Letters 1995; 184: 90–93
  • Fraser P.E., Nguyen J.T., Inouye H., Surewicz W.K., Selkoe D.J., Podusny M.B., Kirschner D.A. Fibril formation by primate, rodent, and Dutch-hemorrhage analogue of Alzheimer amyloid β-protein. Biochemistry 1992; 31: 10716–10723
  • Frautschy S.A., Baird A., Cole G.M. Effects of injected Alzheimer β-amyloid cores in rat brain. Proceedings of the National Academy of Sciences, USA 1991; 88: 8362–8366
  • Frisoni G.B., Calabresi L., Geroldi C., Bi-Anchetti A., D'Acquarica A.L., Govoni S., Sirtori C.R., Trabucchi M., Franceschini G. Apolipoprotein E ε4 allele in Alzheimer's disease and vascular dementia. Dementia 1994; 5: 240–242
  • Fukuchi K., Sopher B., Furlong C.E., Smith A.C., Dang N.T., Martin G.M. Selective neurotoxicity of COOH-terminal fragments of the β-amyloid precursor protein. Neuroscience Letters 1993; 154: 145–148
  • Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Giodo T., Hagopian S., Johnson-Wood K., Khan K., Lee M., EiBowrrz LP., Lieberburg I., Littele S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995; 373: 523–527
  • Garver T.D., Harris K.A., Lehman R.A.W., Lee V. M.-Y., Trojanowski J.Q., Billingsley M.L. τ phosphorylation in human, primate and rat brain: Evidence that a pool of τ is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro. Journal of Neurochemistry 1994; 63: 2279–2287
  • Gentleman S.M., Perl D., Allsop D., Clinton J., Royston M.C., Roberts G.W. Beta (A4)β-amyloid protein and Partrinsonism-demenria complex of Guam. Lancet 1991; 337: 55–56
  • Glenner G.G., Wong C.W. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communication 1984; 120: 885–890
  • Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704–706
  • Goedert M., Wischik C.M., Crowther R.A., Walker J.A., Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau. Proceedings of the National Academy of Sciences, USA 1988; 85: 4051–4055
  • Goedert M., Spillantini M.G., Cairns N.J., Crowther R.A. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 1992; 8: 159–168
  • Golde T.E., Estus S., Younkin L.H., Selkoe D.J., Younkin S.G. Processing of the amyloid protein precursor protein to potentially amyloidogenic derivatives. Science 1992; 255: 728–730
  • Greenberg S.M., Koo E.H., Selkoe D.J., Qiu E.Q., Kosik K.S. Secreted β-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances r phosphorylation. Proceedings of the National Academy of Sciences, USA 1994; 91: 7104–7108
  • Gustke N., Steiner B., Mandelkow E.-M., Bier-Nat J., Meyer H.E., Goedert M., Mandelkow E. The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Letters 1992; 307: 199–205
  • Haan J., Lanser J.B.K., Zijderveld I., van der Does I.G.F., Roos R.A.C. dementia in hereditary cerebral hemmorrhage with amyloidosis-Dutch type. Archives of Neurology 1990; 47: 649–653
  • Harrington C.R., Mukaetova-Ladinska E.B., Hills R., Edwards P.C., Montejo de Garcini E., Novak M., Wischik C.M. Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1991; 88: 5842–5846
  • Harrington C.R., Louwagie J., Rossau R., Van-Mechelen E., Perry R.H., Perry E.K., Xuereb J.H., Roth M., Wischik C.M. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. American Journal of Pathology 1994; 145: 1472–1484
  • Harrington C.R., Roth M., Xuereb J.H., McKenna P.J., Wischik C.M. Apolipoprotein E type ε4 allele frequency is increased in patients with schizophrenia. Neuroscience Letters 1995; 202: 101–104
  • Hasegawa M., Morishima K.M., Takio K., Suzuki M., Titani K., Ihara Y. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. Journal of Biological Chemistry 1992; 267: 17047–17054
  • Helkala E.-L., Koivisto K., Hanninen T., Van-Hanen M., Kervtnen K., Kuusisto J., Mykkanen L., Kesaniemi Y.A., Laakso M., Riekkinen P., Sr. The association of apolipoprotein E polymorphism with memory: A population based study. Neuroscience Letters 1995; 191: 141–144
  • Hendriks L., Van Duijn C.M., Cras P., Cruts M., Van Hul W., Van Harskamp F., Warren A., McInnis M.G., Antonarakis S.E., Martin J.-J., Hofman A., Van Broeckhoven C. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of die β-amyloid precursor protein gene. Nature Genetics 1992; 1: 218–221
  • Huang D.Y., Weisgraber K.H., Goedert M., Saunders A.M., Roses A.D., Strittmatter W.J. ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation. Neuroscience Letters 1995; 192: 109–212
  • Ihara Y. What mediates between β-amyloid and PHF. Neurobiology of Aging 1989; 10: 573–574
  • Iwatsubo T., Odaka A., Suzuki N., Mizusawa N., Nukina N., Ihara Y. Visualisation of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 1994; 13: 45–53
  • Jakes R., Novak M., Davison M., Wischik C.M. Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease. EMBO Journal 1991; 10: 2725–2729
  • Johnson G.V.W., Miller M.L., Troncoso J.C. (1995) The crosslinking of tau into insoluble filaments by transglutaminase. Cytoskeletal Proteins and Neurodegenerative Disease. American Society for Cell Biology, European Molecular Biology Organization, Fourth Joint Meeting, 28. 1995
  • Johnston J.A., Cowburn R.F., Norgren S., Wiehager B., Venizelos N., Winblad B., Vigo-Pelfrey C., Schenk D., Lannfelt L., O'Neill C. Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP 670/671 mutation. FEBS Letters 1994; 354: 274–278
  • Kamtno K., Orr H.T., Payami H., Wijsman E.M., Alonso M.E., Pulst S.M., Anderson L., O'Dahl S., Nemens E., White J.A., Sadovnick A.D., Ball M.J., Kaye J., Warren A., McInnis M., Antonarakis S.E., Korenberg J.R., Sharama V., Kukull W., Larson E., Heston L.L., Martin G.M., Bird T.D., Schellenberg G.D. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. American Journal of Human Genetics 1992; 51: 998–1014
  • Karltnsky H., Vaula G., Haines J.L., Ridgley J., Bergeron C., Morttlla M., Tupler R.G., Percy M.E., Robitaille Y., Noldy N.E., Yip T.C.K., Tanzi R.E., Gusella J.F., Becker R., Berg J.M., Crapper-McLachlan D.R., St George-Hyslop P.H. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a misense mutation in codon 717 of the β-amyloid precursor protein gene. Neurology 1992; 42: 1445–1453
  • Kennedy A.M., Newman S., McKaddon A., Ball J., Roques P., Mullan M., Hardy J., Chartier-Harlin M.-C., Frackwiak R.S.J., Warrington E.K., Rossor M.N. Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine- glycine). Brain 1993; 116: 309–324
  • Kiuchi A., Otsuka N., Namba Y., Nakano I., Tomonaga M. Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathologica (Berl) 1991; 82: 1–5
  • Korneyev A., Binder L., Bernardis J. Rapid phosphorylation of rat brain tau proteins in response to cold water stress. Neuroscience Letters 1995; 191: 19–22
  • Kosik K.S., Orecchio L.D., Binder L.L., Trojanowski J.Q., Lee V. M.-Y., Lee G. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1988; 1: 817–825
  • Kowall N.W., Beal M.F., Busciguo J., Duffy L.K., Yankner B.A. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proceedings of the National Academy of Sciences, USA. 1991; 88: 7247–7251
  • Kraepelin E. Psychiatric: Ein Lehrbuch fur Studierende und Arzte. Qohann Ambrosius Barth, Leipzig 1910
  • Lai R.Y.K., Gertz H. N.-J., Wischik D.J., Xuereb J.H., Mukaetova-Ladinska E.B., Harrington C.R., Edwards P.C., Mena R., Paykel E.S., Brayne C., Huppert F.A., Roth M., Wischik C.M. Examination of phosphorylated tau protein as a PHF-precursor at early stage Alzheimer's disease. Neurobiology of Aging 1995; 16: 433–445
  • Lang E., Szendrei G.I., Lee V. M.-Y., Orvos L., Jr. Immunochemical and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease. Biochemical and Biophysical Research Communications 1992; 187: 783–790
  • Lannfelt L., Bogdanovic N., Appelgren H., Axelman K., Ltuus L., Hansson G., Schenk D., Hardy J., Winblad B. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neuroscience Letters 1994; 168: 254–256
  • Lantos P.L., Luthert P.J., Hanger D., Anderton B.H., Mullan M., Rossor M. Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neuroscience Letters 1992; 137: 221–224
  • Lee V. M.-Y., Balin B.J., Otvos L., Jr, Trojanowski J.Q. A68: A major subunit of paired helical filaments and derivarized forms of normal tau. Science 1991; 251: 675–678
  • Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D., Lieberburg I., Van Duinen S.G., Bots G. T.A. M., Luyendijk W., Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral haemorrhage, Dutch type. Science 1990; 248: 1124–1126
  • Levy-Lahad E., Wijsman E.M., Nemens E., Anderson L., Goddard K.A.B., Weber J.L., Bird T.D., Schellenberg G.D. A familial Alzheimer's disease locus on chromosome 1. Science 1995a; 269: 970–973
  • Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Petttngeu W.H., Yu C.-E., Jondro P.D., Schmidt S.D., Wang K., Crowley A.C., Fu Y.-H., Guenette S.Y., Galas D., Nemens E., Wijsman E.M., Bird T.D., Schellenberg G.D., Tanzi R.E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995b; 269: 973–977
  • Liddell M., Williams J., Bayer A., Kaiser F., Owen M. Confirmation of association between the ε4 allele of apolipoprotein E and Alzheimer's disease. Journal of Medical Genetics 1994; 31: 197–200
  • L'hernault S.W., Arduengo P.M. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. Journal of Cell Biology 1992; 119: 55–68
  • Love S., Bridges L.R., Case C.P. Neurofibrillary tangles in Niemann-Pick disease type C. Brain 1995; 118: 119–129
  • Maat-Scheiman M.L.C., Radder C.M., Van Duinen S.G., Haan J., Rood R.A.C. Hereditary cerebral hemorrhage with amyloidosis (Dutch): A model for congophilic plaque formation without neurofibrillary pathology. Acta Neuro-pathologica (Berl) 1994; 88: 371–378
  • Maccioni R.B., Vera J.C., Dominguez J., Avila J. A discrete repeated sequence defines a tubulin binding domain on microtubule-associated protein tau. Archives of Biochemistry and Biophysics 1988; 275: 568–579
  • Mann D.M.A., Esiri M.M. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. Journal of Neurological Science 1989; 89: 169–179
  • Mann U.M., Mohr E., Gearing M., Chase T.N. Heterogeneity in Alzheimer's disease: Progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. Journal of Neurology, Neurosurgery and Psychiatry 1992; 55: 956–959
  • Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences, USA 1985; 82: 4245–4249
  • Matsuo E.S., Shin R.W., Billingsley M.L., Van de Voorde A., O'Connor M., Trojanowski J.Q., Lee V. M.-Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994; 13: 989–1002
  • Mattson M.P., Barger S.W., Cheng B., Lieberburg I., Smith-Swintosky V.L., Rydel R.E. β-amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends in Neuroscience 1993; 16: 409–414
  • Matus A. Microtubule-associated proteins: Their potential role in determining neuronal morphology. Annual Review of Neuroscience 1988; 11: 29–44
  • Mayeux R., Stern Y., Ottman R., Tatemichi T.K., Tang M.X., Maestre G. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Annals of Neurology 1993; 34: 752–754
  • Mena R., Wischik C.M., Novak M., Milstein C., Cuello A.C. A progressive deposition of paired helical filaments (PHF) in the brain characterizes the evolution of dementia in Alzheimer's disease: An immunocytochemical study with a monoclonal antibody against the PHF core. Journal of Neuropathology and Experimental Neurology 1991; 50: 474–490
  • Mena R., Edwards P., Perez-Olvera O., Wischik C.M. Monitoring pathological assembly of tau and β-amyloid proteins in Alzheimer's disease. Acta Neuropathologica (Berl) 1995; 89: 50–56
  • Mukaetova-Ladinska E.B., Harrington C.R., Roth M., Wischik C.M. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. American Journal of Pathology 1993; 143: 565–578
  • Mukaetova-Ladinska E.B., Harrington C.R., Roth M., Wischik C.M. Distribution of tau protein in Down's syndrome: Quantitative differences from Alzheimer's disease. Developmental Brain Dysfunction 1994; 7: 3113–3129
  • Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genetics 1992a; 1: 345–347
  • Mullan M., Houlden H., Windelspecht M., Fldani L., Lombardi C., Ciaz P., Rossor M., Crook R., Hardy J., Duff K., Crawford F. A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the α1-antichymotrypsin gene. Nature Genetics 1992b; 2: 340–342
  • Murrell J., Farlow M., Ghetti B., Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991; 254: 97–99
  • Nacmias B., Latorraca S., Piersanti P., Forleo P., Piacentini S., Bracco L., Amaducci L., Sorbi S. ApoE genotype and familial Alzheimer's disease: A possible influence on age of onset in APP 717 Val- > lie mutated families. Neuroscience Letters 1995; 183: 1–3
  • Nagy Zs., Esiri M.M., Jobst K.A., Morris J.H., King E. M.-F., McDonald B., Litchfield S., Smith A., Barnetson L., Smith A.D. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: Correlations using three sets of neuropathological criteria. Dementia 1995; 6: 21–31
  • Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreac-tiviry in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Research 1991; 541: 163–166
  • Naruse S., Igarashi S., Kobayashi H., Aoki K., Inuzuka T., Kaneko K., Shimizu T., Ihara K., Kojima T., Miyatake T., Tsuji S. Missense mutation Val-> He in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 1991; 337: 978–979
  • Nathan B.P., Bellosta S., Sanan D.A., Weis-Graber K.H., Mahley R.W., Pitas R.E. Differential effects of apolipoproteins E3 and ε4 on neuronal outgrowth in vitro. Science 1994; 264: 850–852
  • Noguchi S., Murikami K., Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342: 737
  • Novak M., Kabat J., Wischik C.M. Molecular characterization of die minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO Journal 1993; 12: 365–370
  • Papasozomenos S. Ch., Su Y. Altered phosphorylation of tau protein in heat shocked rats and patients with Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1991; 88: 4543–4547
  • Patterson D., Gardiner K., Kao F.-T., Tanzi R., Watkins P., Gusella J. Mapping of die gene encoding the β-amyloid precursor protein and its relationship to die Down syndrome region of chromosome 21. Proceedings of the National Academy of Sciences, USA 1988; 85: 8266–8270
  • Payami H., Kaye J., Heston L.L., Bird T.D., Schellenberg G.D. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342: 738
  • Paykel E.S., Brayne C., Huppert F.A., Gill C., Barkley C., Gehlhaar E., Beardsall L., Girling D., Pollitt P., O'Connor D. Incidence of dementia in an over 75 population in die United Kingdom. Archives of General Psychiatry 1994; 51: 325–332
  • Peacock M.L., Fink J.K. ApoE ε4 allelic association with Alzheimer's disease: Independent confirmation using denaturing gradient gel electrophoresis. Neurology 1994; 44: 339–341
  • Pickering-Brown S.M., Mann D.M.A., Bourke J.P., Roberts D.A., Balderson D., Burns A., Byrne J., Owen F. Apolipoprotein ε4 and Alzheimer's disease pathology in Lewy body disease and in other β-amyloid-forming diseases. Lancet 1994; 343: 1155
  • Poirier J., Hess M., May P.C., Finch C.E. Cloning of hippocampal poiy(A) RNA sequences that increase after entorhinal cortex lesion in adult rat. Molecular Brain Research 1991a; 9: 191–195
  • Poirier J., Hess M., May P.C., Finch C.E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Molecular Brain Research 1991b; 11: 97–106
  • Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342: 697–699
  • Price J.L., Davis P.B., Morris J.C., White D.L. The distribution of tangles, plaques and related immunohistological markers in healthy aging and Alzheimer's disease. Neurobiology of Aging 1991; 12: 295–312
  • Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 1993; 11: 575–580
  • Reed T., Carmelu D., Swan G.E., Breitner J.C.S., Welsh K.A., Jarvik G.P., Deeb S., Auwerx J. Lower cognitive performance in normal older adult male twins carrying die apolipoprotein ε4 allele. Archives of Neurology 1994; 51: 1189–1192
  • Rosemuller A.J.M., Roos R.A.C., Bots G. T. A. M., Kamphorst W., Eikelenboom P., Van Nostrand W.E. Distribution of βA4 protein and amyloid precursor protein in hereditary cerebral hemorrhage widi amyloidosis-Dutch type and Alzheimer's type. American Journal of Pathology 1993; 142: 1449–1457
  • Roth M., Tomlinson B.E., Blessed G. Correlation between scores for dementia and counts of ‘senile plaques’ in cerebral grey matter of elderly subjects. Nature 1966; 209: 109–110
  • Rubin G.C., Iqbal K., Wisniewski H.M., Johnson J.E., Grundke-Iqbal I. Alzheimer neurofibrillary tangles contain 2.1 nm filaments structurally identical to die microtubule-associated protein t. A high resolution transmission electron microscope study of tangles and senile plaque core amyloid. Brain Research 1992; 590: 164–179
  • Saunders A.M., Strittmatter W.J., Schmechel D., St George-Hyslop P.H., Pericak Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1462–1472
  • Schellenberg G.D., Bird T.D., Wijsman E.M., Moore D.K., Boehnke M., Bryant E.M., Lampe T.H., Nochun D., Sumi S.M., Deeb S.S., Beyreuther K., Martin G.M. Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. Science 1988; 241: 1507–1510
  • Schellenberg G.D., Bird T.D., Wijsman E.M., Orr H.T., Anderson L., Nemens E., White J.A., Bonnycastle L., Weber J.L., Alonso M.E., Potter H., Heston L.L., Martin G.M. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992; 258: 668–671
  • Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1993; 90: 9649–9653
  • Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Pounsky R.J., Wasco W., Da Silva H.A.R., Haines J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754–760
  • Shimano H., Ishibashi S., Murase T., Gotohda T., Yamada N., Takaku F., Ohtomo E. Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis 1989; 79: 257–260
  • Shin R.W., Bramblett G., Lee V. M.-Y, Tro-Janowski J.Q. Alzheimer disease A68 proteins injected into rat brain induce codeposits of β-amyloid, ubiquitin and α1-antichymotrypsin. Proceedings of the National Academy of Sciences, USA 1993; 90: 6825–6828
  • Soininen H., Partanen K., Pitkanen A., Halukainen M., Hanninen T., Heusalmi S., Mannermaa A., Ryynanen M., Koivisto K., Riekkinen P., Sr. Decreased hippocampal volume assymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ε4 allele. Neurology 1995; 45: 391–392
  • Sorbi S., Nacmias B., Forleo P., Piacentini S., Latorraca S., Amaducci L. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Annals of Neurology 1995a; 38: 124–127
  • Sorbi S., Nacmias B., Forleo P., Piacentini S., Sherrington R., Rogaev E., St George-Hyslop P., Amaducci L. Missense mutation of S182 gene in Italian families with early-onset Alzheimer's disease. Lancet 1995b; 346: 439–440
  • St Clair D., Norrman J., Perry R., Yates C., Wilcock G., Brookes A. Apolipoprotein E ε4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neuroscience Letters 1994; 176: 45–46
  • St George-Hyslop P., Haines J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., Foncin J.-F., Montesi M., Bruni A., Sorbi S., Rainero I., Pinessi L., Pollen D., Polinsky R., Nee L., Kennedy J., Macciardi F., Rogaeva E., Liang Y., Alexandrova N., Luktw W., Schlumpf K., Tanzi R., Tsuda T., Farrer L., Cantu J.-M., Duara R., Amaducci L., Bergamini L., Gusella J., Roses A., Crapper-McLachlan D. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genetics 1992; 2: 330–334
  • Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: High avidity to beta-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1993; 90: 1977–1981
  • Strittmatter W.J., Weisgraber K.H., Goedert M., Saunders A.M., Huang D., Corder E.H., Dong L.-M., Jakes R., Alberts M.J., Gilbert J.R., Han S.-H., Hulette C., Einstein G., Schmechel D.E., Pericak-Vance M.A., Roses A.D. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Experimental Neurology 1994; 125: 163–171
  • Strittmatter W.J., Roses A.D. Apolipoprotein E and Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1995; 92: 4725–4727
  • Suzuki N., Cheung T.T., Cai X.-D., Otvos L., Eckman X., Golde T., Younkin S.G. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 1994; 264: 1336–1340
  • Tagliavini F., Giaccone G., Bugiani O., Frangione B. Ubiquitinated neurites are associated with preamyloid and cerebral amyloid β deposits in patients with hereditary cerebral hemorrhage with amyloidosis Dutch type. Acta Neuropathologica (Berl) 1993; 85: 267–271
  • Tanahashi H., Mitsunaga Y., Takahashi K., Tasaki H., Watanabe S., Tabira T. Missense mutation of S182 gene in Japanese familial Alzheimer's disease. Lancet 1995; 346: 440
  • Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A.P., St George-Hyslop P., Van Keuren M.L., Patterson D., Pagan S., Kurnit D.M., Neve R.L. Amyloid beta protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 1987; 235: 880–884
  • Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology 1991; 30: 572–580
  • Tsuda T., Chi H., Liang Y., Rogaeva E.A., Sherrington R., Levesque G., Ikeda M., Rogaev E.I., Pollen D., Freedman M., Duara R., St George-Hyslop P.M. Failure to detect missense mutations in the si 82 gene in a series of late-onset Alzheimer's disease cases. Neuroscience Letters 1995; 201: 188–190
  • Van Broeckhoven C., Backhovens H., Cruts M., de Winter G., Bruyland M., Cras P., Martin J.-J. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nature Genetics 1992; 2: 335–339
  • Van Broeckhoven C., Backhovens H., Cruts M., Martin J.J., Crook R., Houlden H., Hardy J. APOE genotype does not modulate age of onset in families with chromosome encoded Alzheimer's disease. Neuroscience Letters 1994; 169: 179–180
  • Van Duijn C.M., Hendriks L., Cruts M., Hardy J.A., Hofman A., Van Broeckhoven C. Amyloid precursor-protein gene mutation in early-onset Alzheimer disease. Lancet 1991; 337: 978
  • Van Duijn C.M., de Knijff P., Wehnert A., de Voecht J., Bronzova J.B., Havekes L.M., Hofman A., Van Broeckhoven C. The apolipoprotein E e2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Annals of Neurology 1995; 37: 605–610
  • Waring S.C., O'Brien P.C., Kurland L.T., Thi-Bodeau S.N., Tsai M.-S., Petersen R.C., Este-ban-Santillan C.E. Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/ parkinsonism-dementia complex. Lancet 1994; 343: 611
  • Wilcock G.K., Esiri M.M. Plaques, tangles and dementia—a quantitative study. Journal of Neurological Science 1982; 56: 343–356
  • Wille H., Drewes G., Biernat J., Mandelkow E.-M., Mandelkow E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. Journal of Cell Biology 1992; 118: 573–584
  • Wilson D.M., Kuret J., Binder L.I. (1995) Induction and polarity of tau polymerization into AD-like straight filaments.Cytoskeletal Proteins and Neurodegenerative Disease. American Society for Cell Biology, European Molecular Biology Organization, Fourth Joint Meeting, 28. 1995
  • Wischik C.M., Crowther R.A., Stewart M., Roth M. Subunit structure of the paired helical filament of Alzheimer's disease. Journal of Cell Biology 1985; 100: 1905–1912
  • Wischik C.M., Novak M., Thogersen H.C., Edwards P.C., Runswick M.J., Jakes R., Walker J.E., Milstein C., Roth M., Klug A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proceedings of the National Academy of Sciences, USA 1988; 85: 4506–4510
  • Wischik C.M. Cell biology of the Alzheimer tangle. Current Opinion in Cell Biology 1989; 1: 115–122
  • Wischik C.M., Harrington C.R., Lai R.Y.K., Mukaetova-Ladinska E.B., Xuereb J.H., Gertz H., Wischik D.J., Edwards P.C., Roth M. What causes neurofibrillary tangle formation in Alzheimer's disease?. Neurobiology of Aging 1995; 16: 423–431
  • Wisniewski T., Frangione B. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neuroscience Letters 1992; 135: 235–238
  • Wisniewski T., Castano E.M., Golabek A., Vogel T., Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. American Journal of Pathology 1994; 145: 1030–1035
  • Yoshioka K., Miki T., Katsuya T., Ogihara T., Sakaki Y. The 717 Val->Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups. Biochemical and Biophysical Research Communications 1991; 178: 1141–1146
  • Zubenko G.S., Stiffler S., Stabler S., Kopp U., Hughes H.B., Cohen B.M., Moossy J. Association of the apolipoprotein E ε4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. American Journal of Medical Genetics (Neuro-psychiatric Genetics) 1994; 54: 199–205

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.